Ignite Creation Date:
2025-12-24 @ 3:39 PM
Ignite Modification Date:
2026-03-01 @ 9:58 AM
Study NCT ID:
NCT06095492
Status:
RECRUITING
Last Update Posted:
2024-12-05
First Post:
2023-09-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
Sponsor:
Medanta, The Medicity, India
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MMENDO01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None